(1) APPLICABILITY.—The amendment made by 
subsection (a) shall apply to convictions for offenses 
described in the matter inserted by such amendment 
occurring before, on, and after the date of enact-
ment of this Act. 
(2) RESUMPTION
OF
ELIGIBILITY.—Any stu-
dent whose eligibility for grants, loans, and work as-
sistance under title IV of the Higher Education Act 
of 1965 (20 U.S.C. 1070 et seq.) was suspended 
under section 484(r)(1) of such Act by reason of a 
conviction, before the date of enactment of this Act, 
for an offense described in the matter inserted by 
the amendment made by subsection (a) shall, unless 
otherwise ineligible for such assistance, resume eligi-
bility upon such date of enactment. 
SEC. 304. CIVIL FORFEITURE EXEMPTION FOR MARIJUANA 
FACILITIES AUTHORIZED BY STATE LAW. 
Section 511(a)(7) of the Controlled Substances Act 
(21 U.S.C. 881(a)(7)) is amended— 
(1) by striking ‘‘(7) All’’ and inserting ‘‘(7)(A) 
Except as provided in subparagraph (B), all’’; and 
(2) by adding at the end the following: 
‘‘(B) No real property, including any right, 
title, and interest in the whole of any lot or tract of 
land and any appurtenances or improvements, shall 
VerDate Sep 11 2014 
20:16 Apr 05, 2017
Jkt 069200
PO 00000
Frm 00026
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
be subject to forfeiture under subparagraph (A) due 
to marijuana-related conduct that is authorized by 
State law or the law of the Indian tribe, as defined 
in section 4 of the Indian Self-Determination and 
Education Assistance Act (25 U.S.C. 5304), that 
has jurisdiction over the Indian country, as defined 
in section 1151 of title 18, United States Code, in 
which the conduct occurs.’’. 
SEC. 305. PROHIBITION ON INADMISSIBILITY OR DEPORTA-
TION OF ALIENS WHO COMPLY WITH STATE 
LAW. 
(a) PROHIBITION
ON
INADMISSIBILITY.—Section 
212(a)(2)(A)(i)(II) of the Immigration and Nationality 
Act (8 U.S.C. 1182(a)(2)(A)(i)(II)) is amended by insert-
ing ‘‘other than an act involving marijuana that is per-
mitted under the laws of a State or the law of an Indian 
tribe, as defined in section 4 of the Indian Self-Determina-
tion and Education Assistance Act (25 U.S.C. 5304), that 
has jurisdiction over the Indian country, as defined in sec-
tion 1151 of title 18, United States Code, in which the 
act occurs’’ after ‘‘802)),’’. 
(b) 
PROHIBITION
ON
DEPORTATION.—Section 
237(a)(2)(B)(i) of the Immigration and Nationality Act 
(8 U.S.C. 1227(a)(2)(B)(i)) is amended by striking ‘‘mari-
juana,’’ and inserting ‘‘marijuana or an offense involving 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00027
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
marijuana that is permitted under the laws of a State or 
the law of an Indian tribe, as defined in section 4 of the 
Indian Self-Determination and Education Assistance Act 
(25 U.S.C. 5304), that has jurisdiction over the Indian 
country, as defined in section 1151 of title 18, United 
States Code, in which the offense occurs’’. 
SEC. 306. DRUG-RELATED CRIMINAL ACTIVITY IN FEDER-
ALLY ASSISTED HOUSING. 
(a) IN GENERAL.—Section 3(b) of the United States 
Housing Act of 1937 (42 U.S.C. 1437a(b)) is amended— 
(1) by striking paragraph (9) and inserting the 
following: 
‘‘(9) DRUG-RELATED CRIMINAL ACTIVITY.—The 
term ‘drug-related criminal activity’— 
‘‘(A) means the illegal manufacture, sale, 
distribution, use, or possession with intent to 
manufacture, sell, distribute, or use, of a con-
trolled substance (as defined in section 102 of 
the Controlled Substances Act (21 U.S.C. 
802)); and 
‘‘(B) does not include the manufacture, 
sale, distribution, use, or possession with intent 
to manufacture, sell, distribute, or use, of mari-
juana if such activity is conducted in compli-
ance with State law or the law of the Indian 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00028
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
tribe that has jurisdiction over the Indian coun-
try where the activity occurs.’’; and 
(2) by adding at the end the following: 
‘‘(14) INDIAN
COUNTRY.—The term ‘Indian 
country’ has the meaning given the term in section 
1151 of title 18, United States Code. 
‘‘(15) INDIAN TRIBE.—The term ‘Indian tribe’ 
has the meaning given the term in section 4 of the 
Indian Self-Determination and Education Assistance 
Act (25 U.S.C. 5304). 
‘‘(16) MARIJUANA.—The term ‘marijuana’ has 
the meaning given the term in section 102 of the 
Controlled Substances Act (21 U.S.C. 802).’’. 
(b) TECHNICAL AND CONFORMING AMENDMENTS.— 
(1) QUALITY HOUSING AND WORK RESPONSI-
BILITY ACT OF 1998.—Section 576 of the Quality 
Housing and Work Responsibility Act of 1998 (42 
U.S.C. 13661) is amended by striking ‘‘(as such 
term is defined in section 3(b) of the United States 
Housing Act of 1937 (42 U.S.C. 1437a(b))’’. 
(2) UNITED STATES HOUSING ACT OF 1937.— 
The United States Housing Act of 1937 (42 U.S.C. 
1437 et seq.) is amended— 
(A) in section 6(l) (42 U.S.C. 1437d(l))— 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00029
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
(i) by redesignating the second para-
graph designated as paragraph (7) (relat-
ing to violations as cause for termination 
of tenancy) as paragraph (8); 
(ii) in paragraph (9), by redesignating 
paragraph (2) as subparagraph (B), and 
adjusting the margins accordingly; and 
(iii) by striking the flush text fol-
lowing paragraph (9)(B), as so redesig-
nated; and 
(B) in section 8(f) (42 U.S.C. 1437f(f))— 
(i) by striking paragraph (5); and 
(ii) by redesignating paragraphs (6) 
and (7) as paragraphs (5) and (6), respec-
tively. 
TITLE IV—MEDICAL MARIJUANA 
RESEARCH AND ACCESS 
SEC. 401. MEDICAL MARIJUANA RESEARCH ACT. 
(a) SHORT TITLE.—This section may be cited as the 
‘‘Medical Marijuana Research Act of 2017’’. 
(b) DEFINITIONS.—In this section— 
(1) the term ‘‘qualified medical marijuana re-
searcher’’ means a researcher who is registered to 
conduct research with marijuana under section 
303(f)(3) of the Controlled Substances Act (21 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00030
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
U.S.C. 823(f)(3)), as amended by subsection (d); 
and 
(2) the term ‘‘Secretary’’ means the Secretary 
of Health and Human Services. 
(c) PRODUCTION AND SUPPLY.— 
(1) IN GENERAL.—The Secretary— 
(A) until the date on which the Secretary 
determines that manufacturers and distributors 
(other than the Federal Government) can en-
sure a sufficient supply of marijuana for quali-
fied medical marijuana researchers, shall— 
(i) continue to produce marijuana 
through the National Institute on Drug 
Abuse Drug Supply Program; and 
(ii) offer for sale immature marijuana 
plants and the seeds of marijuana— 
(I) to all qualified medical mari-
juana researchers who submit a re-
quest for such plants or seeds to en-
gage in research pursuant to section 
303(f)(3) of the Controlled Sub-
stances Act (21 U.S.C. 823(f)(3)), as 
amended by subsection (d); and 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00031
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
(II) in quantities sufficient to 
produce an adequate supply of mari-
juana for such research; and 
(B) beyond the date specified in subpara-
graph (A), may, at the Secretary’s discretion, 
continue to so produce and supply marijuana. 
(2) REQUIREMENT
TO
VERIFY
REGISTRA-
TION.—Before supplying marijuana to any person 
through the National Institute on Drug Abuse Drug 
Supply Program, the Secretary shall— 
(A) require the person to submit docu-
mentation demonstrating that the person is a 
qualified medical marijuana researcher seeking 
to conduct research pursuant to the section 
303(f)(3) of the Controlled Substances Act (21 
U.S.C. 823(f)(3)), as amended by subsection 
(d); and 
(B) not later than 30 days after receipt of 
such documentation, review such documentation 
and verify that the marijuana will be used for 
such research. 
(3) GUIDELINES ON PRODUCTION.—The Com-
missioner of Food and Drugs, in consultation with 
the Director of the National Institute on Drug 
Abuse, shall— 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00032
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
(A) not later than 180 days after the date 
of enactment of this Act, issue guidelines on the 
production of marijuana by qualified medical 
marijuana researchers pursuant to paragraph 
(1)(A)(ii); and 
(B) encourage researchers and manufac-
turers that are authorized to produce or manu-
facture marijuana pursuant to section 303 of 
the Controlled Substances Act (21 U.S.C. 823), 
as amended by this section, to comply with such 
guidelines to the extent applicable. 
(4) DEFINITION.—In this subsection, the term 
‘‘immature marijuana plant’’ means a marijuana 
plant with no observable flowers or buds. 
(d) FACILITATING MARIJUANA RESEARCH.— 
(1) IN GENERAL.—Section 303(f) of the Con-
trolled Substances Act (21 U.S.C. 823(f)) is amend-
ed— 
(A) 
by 
redesignating 
paragraphs 
(1) 
through (5) as subparagraphs (A) through (E), 
respectively; 
(B) by striking ‘‘(f) The Attorney General’’ 
and inserting ‘‘(f)(1) The Attorney General’’; 
(C) by striking ‘‘Registration applications’’ 
and inserting the following: 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00033
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
‘‘(2) Registration applications’’; 
(D) in paragraph (2), as so designated, by 
striking ‘‘schedule I’’ each place that term ap-
pears and inserting ‘‘schedule I, except mari-
juana,’’; 
(E) by striking ‘‘Article 7’’ and inserting 
the following: 
‘‘(4) Article 7’’; and 
(F) by inserting before paragraph (4), as 
so designated, the following: 
‘‘(3)(A) The Attorney General shall register a practi-
tioner to conduct research with marijuana if— 
‘‘(i) the applicant is authorized to dispense, or 
conduct research with respect to, controlled sub-
stances in schedules II, III, IV, and V under the 
laws of the State in which the applicant practices; 
‘‘(ii) the applicant’s research protocol— 
‘‘(I) has been reviewed and allowed by— 
‘‘(aa) the Secretary under section 
505(i) of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 355(i)); or 
‘‘(bb) the National Institutes of 
Health or another Federal agency that 
funds scientific research; or 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00034
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
‘‘(II) in the case of nonhuman research 
that is not federally funded, has been volun-
tarily submitted by the applicant to, and ap-
proved by, the National Institutes of Health; 
and 
‘‘(iii) the applicant has demonstrated that there 
are effective procedures in place to adequately safe-
guard against diversion of the marijuana from legiti-
mate medical or scientific use, in accordance with 
subparagraph (E). 
‘‘(B) The Attorney General shall grant an application 
for registration under this paragraph unless the Attorney 
General determines that the issuance of the registration 
would be inconsistent with the public interest. In deter-
mining the public interest, the following factors shall be 
considered: 
‘‘(i) The applicant’s experience in dispensing, or 
conducting research with respect to, controlled sub-
stances. 
‘‘(ii) The applicant’s conviction record under 
Federal or State laws relating to the manufacture, 
distribution, or dispensing of controlled substances. 
‘‘(iii) Compliance with applicable State, Fed-
eral, or local laws relating to controlled substances. 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00035
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
‘‘(iv) Such other conduct by the applicant that 
may threaten the public health and safety. 
‘‘(C) Not later than 90 days after the date of enact-
ment of the Medical Marijuana Research Act of 2017, for 
purposes of subparagraph (A)(ii)(II), the National Insti-
tutes of Health shall establish a process that— 
‘‘(i) allows a researcher to voluntarily submit 
the research protocol of the researcher for review 
and approval; and 
‘‘(ii) provides a researcher described in clause 
(i) with a decision not less than 30 days after the 
date on which the research protocol is submitted. 
‘‘(D)(i) Not later than 60 days after the date on 
which the Attorney General receives a complete applica-
tion for registration under this paragraph, the Attorney 
General shall approve or deny the application. 
‘‘(ii) For purposes of clause (i), an application shall 
be deemed complete when the applicant has submitted 
documentation showing that the requirements under sub-
paragraph (A) are satisfied. 
‘‘(E)(i) A researcher registered under this paragraph 
shall store marijuana to be used in research in a securely 
locked, substantially constructed cabinet. 
‘‘(ii) Except as provided in clause (i), any security 
measures required by the Attorney General for practi-
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00036
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
tioners conducting research with marijuana pursuant to 
a registration under this paragraph shall be consistent 
with the security measures for practitioners conducting re-
search on other controlled substances in schedule II that 
have a similar risk of diversion and abuse. 
‘‘(F)(i) If the Attorney General grants an application 
for registration under this paragraph, the applicant may 
amend or supplement the research protocol without re-
applying if the applicant does not— 
‘‘(I) change the type of drug, the source of the 
drug, or the conditions under which the drug is 
stored, tracked, or administered; or 
‘‘(II) otherwise increase the risk of diversion. 
‘‘(ii) If an applicant amends or supplements the re-
search protocol or initiates research on a new research 
protocol under clause (i), the applicant shall, in order to 
renew the registration under this paragraph, provide no-
tice to the Attorney General of the amended or supple-
mented research protocol or any new research protocol in 
the applicant’s renewal materials. 
‘‘(iii)(I) If an applicant amends or supplements a re-
search protocol and the amendment or supplement in-
volves a change to the type of drug, the source of the drug, 
or conditions under which the drug is stored, tracked, or 
administered or otherwise increases the risk of diversion, 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00037
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
the applicant shall provide notice to the Attorney General 
not later than 30 days before proceeding on such amended 
or supplemental research or new research protocol, as the 
case may be. 
‘‘(II) If the Attorney General does not object during 
the 30-day period following a notification under subclause 
(I), the applicant may proceed with the amended or sup-
plemental research or new research protocol. 
‘‘(iv) The Attorney General may object to an amend-
ed or supplemental protocol or a new research protocol 
under clause (i) or (iii) only if additional security meas-
ures are needed to safeguard against diversion or abuse. 
‘‘(G) If marijuana or a compound of marijuana is 
listed on a schedule other than schedule I, the provisions 
of paragraphs (1), (2), and (4) that apply to research with 
a controlled substance in the applicable schedule shall 
apply to research with marijuana or that compound, as 
applicable, in lieu of the provisions of subparagraphs (A) 
through (F) of this paragraph.’’. 
(2) 
CONFORMING
AMENDMENT.—Section 
102(16) of the Controlled Substances Act (21 
U.S.C. 802(16)) is amended by inserting ‘‘or ‘mari-
juana’ ’’ after ‘‘The term ‘marihuana’ ’’. 
(e) MANUFACTURE AND DISTRIBUTION OF MARI-
JUANA FOR USE IN LEGITIMATE, MEDICAL RESEARCH.— 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00038
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
Section 303 of the Controlled Substances Act (21 U.S.C. 
823), as amended by subsection (d), is further amended 
by adding at the end the following: 
‘‘(k) REGISTRATION OF PERSONS TO MANUFACTURE 
AND DISTRIBUTE MARIJUANA FOR USE IN LEGITIMATE, 
MEDICAL RESEARCH.— 
‘‘(1) REGISTRATION OF MANUFACTURERS.—Be-
ginning not later than the day that is 1 year after 
the date of enactment of the Medical Marijuana Re-
search Act of 2017, the Attorney General shall reg-
ister an applicant to manufacture marijuana to the 
extent the marijuana will be used exclusively by 
qualified medical marijuana researchers for research 
pursuant to subsection (f)(3), unless the Attorney 
General determines that the issuance of such reg-
istration is inconsistent with the public interest. In 
determining the public interest, the Attorney Gen-
eral shall— 
‘‘(A) take into consideration— 
‘‘(i) maintenance of effective controls 
against diversion of marijuana and any 
controlled substance compounded there-
from into other than legitimate medical, 
scientific, or research channels; 
VerDate Sep 11 2014 
03:06 Apr 05, 2017
Jkt 069200
PO 00000
Frm 00039
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
‘‘(ii) compliance with applicable State 
and local law; and 
‘‘(iii) prior conviction record of the 
applicant under Federal or State laws re-
lating to the manufacture, distribution, or 
dispensing of such substances; and 
‘‘(B) not take into consideration any fac-
tors other than the factors listed in subpara-
graph (A). 
‘‘(2) REGISTRATION OF DISTRIBUTORS.—Begin-
ning not later than the day that is 1 year after the 
date of enactment of the Medical Marijuana Re-
search Act of 2017, the Attorney General shall reg-
ister an applicant to distribute marijuana that is in-
tended to be used exclusively by qualified medical 
marijuana researchers for research pursuant to sub-
section (f)(3), unless the Attorney General deter-
mines that the issuance of such registration is incon-
sistent with the public interest. In determining the 
public interest, the Attorney General shall— 
‘‘(A) take into consideration— 
‘‘(i) maintenance of effective controls 
against diversion of marijuana and any 
controlled substance compounded there-
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00040
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
from into other than legitimate medical, 
scientific, or research channels; 
‘‘(ii) compliance with applicable State 
and local law; 
‘‘(iii) prior conviction record of the 
applicant under Federal or State laws re-
lating to the manufacture, distribution, or 
dispensing of such substances; and 
‘‘(iv) past experience in the distribu-
tion of controlled substances, and the exist-
ence in the establishment of effective con-
trols against diversion; and 
‘‘(B) not take into consideration any fac-
tors other than the factors listed in subpara-
graph (A). 
‘‘(3) NO LIMIT ON NUMBER OF MANUFACTUR-
ERS
AND
DISTRIBUTORS.—Notwithstanding any 
other provision of law, the Attorney General shall 
not impose or implement any limit on the number of 
persons eligible to be registered to manufacture or 
distribute marijuana pursuant to paragraph (1) or 
(2). 
‘‘(4) REQUIREMENT TO VERIFY USE FOR LE-
GITIMATE, MEDICAL RESEARCH.—As a condition on 
registration under this section to manufacture or 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00041
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS
distribute marijuana, the Attorney General shall re-
quire the registrant— 
‘‘(A) to require any person to whom the 
marijuana will be supplied to submit docu-
mentation demonstrating that the marijuana 
will be used exclusively by qualified medical 
marijuana researchers for research pursuant to 
subsection (f)(3); and 
‘‘(B) not later than 30 days after receipt 
of such documentation, and before supplying 
the marijuana to such person, to review such 
documentation and verify that the marijuana 
will be so used. 
‘‘(5) TIMING.—Not later than 30 days after re-
ceipt of a request for registration under this sub-
section to manufacture or distribute marijuana, the 
Attorney General shall— 
‘‘(A) grant or deny the request; and 
‘‘(B) in the case of a denial, provide a 
written explanation of the basis for the denial. 
‘‘(6) DEFINITION.—For purposes of this sub-
section, the term ‘qualified medical marijuana re-
searcher’ means a researcher who is registered to 
conduct research with marijuana under subsection 
(f)(3).’’. 
VerDate Sep 11 2014 
04:28 Apr 04, 2017
Jkt 069200
PO 00000
Frm 00042
Fmt 6652
Sfmt 6201
E:\BILLS\H1824.IH
H1824
lotter on DSK5VPTVN1PROD with BILLS